Arteris (AIP) drew fresh attention after SiEngine Technology licensed its FlexNoC interconnect IP for next generation automotive SoCs focused on intelligent cockpit and driver assistance, extending an existing multi generation collaboration.

That new SiEngine agreement lands at a time when Arteris has already been on a strong run, with a 30 day share price return of 21.58% and a 90 day share price return of 168.64%, while the 1 year total shareholder return of 407.59% and 3 year total shareholder return of about 6x show how much sentiment around the company has shifted.

If you are interested in how other chip and IP suppliers are being priced after design wins and partnerships, this could be a good moment to scan 49 AI infrastructure stocks

With Arteris now trading around $44.11 after a very strong 1 year and 3 year run, along with revenue growth of 23.22% and a recent loss of $34.584 million, is this surge overdone, or are markets only starting to price in future growth?

Most Popular Narrative: 17% Overvalued

Compared with the most followed narrative fair value of $37.75, Arteris at $44.11 is priced above what those models suggest, pointing to very optimistic expectations already in the share price.

Growth in remaining performance obligations (RPO), up 28% year over year, signals a solid and expanding contractual revenue base, providing confidence in forward revenue realization and supporting operating leverage as R&D investments start to scale with increased deployment of Arteris' solutions.

Want to see what is built into that fair value for Arteris? The narrative leans on fast revenue compounding, improving margins, and a rich future earnings multiple. Curious how those pieces fit together?

Result: Fair Value of $37.75 (OVERVALUED)

However, Arteris still carries meaningful risks, including ongoing losses of $34.584 million and reliance on large customers that could shift spending or insource IP.

Next Steps

The combination of strong share price gains and ongoing losses at Arteris can leave sentiment feeling stretched in both directions. Move quickly and inspect the details yourself, then weigh up the 1 key reward and 2 important warning signs by reviewing the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Arteris?

Arteris might be front of mind today, but your next strong opportunity could be sitting elsewhere. Give yourself options rather than relying on a single stock.

• Target potential bargains with healthy fundamentals by scanning the 44 high quality undervalued stocks to see which companies currently line up with your return and risk expectations.
• Prioritize resilience and sleep easier at night by reviewing the 69 resilient stocks with low risk scores to find companies with profiles that may better suit cautious capital.
• Spot underfollowed opportunities early by running through the screener containing 19 high quality undiscovered gems before the wider market catches on and pushes valuations higher.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.